🏛️ Verified NIH Record • Updated 2026-03-10
Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye (NCT02846571)
🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic Sponsor: Midhat H. Abdulreda
🩺 Plain-English Summary (8th-Grade Level)
The intervention in this trial is intraocular islet transplantation. A single dose of 1000 - 3000 Islet Equivalents (IEQ)/kg recipient body weight (BW) will be infused into the anterior chamber of the eye through a self-sealing incision in the peripheral cornea. The procedure is projected to take approximately 20-30 minutes. Transplant recipients in this study will receive localized maintenance immunosuppression via topical application of eye-drops.
Who can join: Review the eligibility criteria below.
Location: Bascom Palmer Eye Institute — Miami, Florida
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Bascom Palmer Eye Institute — Miami, Florida
- Diabetes Research Institute, University of Miami Miller School of Medicine — Miami, Florida
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.